2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
222 4
Ultima descărcare din IBN:
2023-09-13 16:42
SM ISO690:2012
MACH, Francois, BAIGENT, Colin N., CATAPANO, Alberico L., NOI, Autori, IVANOV, Victoria. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.. In: European Heart Journal, 2020, vol. 41, pp. 140-205. ISSN 0195-668X. DOI: https://doi.org/10.1093/eurheartj/ehz455
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Heart Journal
Volumul 41 / 2020 / ISSN 0195-668X

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Erratum in:

Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

DOI:https://doi.org/10.1093/eurheartj/ehz455

Pag. 140-205

MacH Francois1, Baigent Colin N.2, Catapano Alberico L.3, Noi Autori, Ivanov Victoria4
 
1 Medicine University of Geneva,
2 University of Oxford,
3 University of Milan,
4 Moldavian Society of Cardiology
 
 
Disponibil în IBN: 1 martie 2023


Cuvinte-cheie
adult, Aged, biomarkers, cardiovascular diseases, consensus, drug therapy, Combination, dyslipidemias, female, Humans, Hypolipidemic Agents, lipids, Male, middle aged, risk assessment, risk factors, Risk Reduction Behavior, treatment outcome